Learn how AI in drug discovery is revolutionizing therapeutic development and addressing challenges in cell and gene therapy.

Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.

Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic ...

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics data generation for biomarker discovery and clinical ... of samples — enables rapid drug target identification, biomarker discovery ...